The average one-year price target for Replimune Group (NasdaqGS:REPL) has been revised to $12.82 / share. This is an increase of 10.52% from the prior estimate of $11.60 dated November 14, 2025. The ...

Maybe you’re a closet Clojure or Scala developer, or perhaps you’ve worked with LISP in the past. If so, there’s a good chance you’ve used a REPL as a part of your daily routine. REPL, or ...

I've been keeping an eye on Rudrabhishek Enterprises Limited (NSE:REPL) because I'm attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe REPL ...

Replimune Group, Inc.'s stock has fallen 35% in 2024, and an inflection point is not expected yet. The company is working on RP1, an oncolytic virus therapy, and has shared positive results from their ...

When Rudrabhishek Enterprises Limited’s (NSE:REPL) announced its latest earnings (31 March 2018), I wanted to understand how these figures stacked up against its past performance. The two benchmarks I ...

The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions as of June 28 ...

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...